Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-23

Clinical Trial Update: Maximizing Visual Outcomes With Eyhance IOLs

View source ↗

Summary

A clinical trial update reporting completed results for Eyhance intraocular lenses in pseudophakia patients, aimed at maximizing visual outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Berkeley Eye Center | Conditions: Pseudophakia | Status: COMPLETED | Results posted: 2025-05-23